Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammary Glands, Animal | 16 | 2020 | 71 | 3.700 |
Why?
|
| Tannins | 5 | 2022 | 17 | 3.410 |
Why?
|
| Epithelial Cells | 9 | 2019 | 431 | 1.990 |
Why?
|
| Collagen Type I | 3 | 2020 | 175 | 1.700 |
Why?
|
| Biocompatible Materials | 5 | 2022 | 247 | 1.670 |
Why?
|
| Hydrogels | 2 | 2022 | 54 | 1.560 |
Why?
|
| Cell Differentiation | 10 | 2019 | 1034 | 1.440 |
Why?
|
| Breast Neoplasms | 5 | 2019 | 1533 | 1.260 |
Why?
|
| Cell Proliferation | 11 | 2017 | 1174 | 1.230 |
Why?
|
| Mammary Neoplasms, Animal | 3 | 2017 | 44 | 1.210 |
Why?
|
| Breast | 2 | 2019 | 137 | 1.040 |
Why?
|
| Tissue Scaffolds | 2 | 2020 | 111 | 1.030 |
Why?
|
| Stem Cells | 4 | 2013 | 248 | 0.980 |
Why?
|
| Gene Expression Profiling | 3 | 2017 | 498 | 0.980 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2017 | 146 | 0.970 |
Why?
|
| Transforming Growth Factor alpha | 3 | 2007 | 30 | 0.890 |
Why?
|
| Receptor, ErbB-2 | 3 | 2017 | 128 | 0.770 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2019 | 235 | 0.760 |
Why?
|
| Mammary Glands, Human | 3 | 2010 | 33 | 0.760 |
Why?
|
| Cell Line, Tumor | 8 | 2020 | 1851 | 0.740 |
Why?
|
| Tissue Engineering | 2 | 2020 | 212 | 0.730 |
Why?
|
| Apoptosis | 3 | 2017 | 1641 | 0.720 |
Why?
|
| Amphiregulin | 2 | 2017 | 19 | 0.700 |
Why?
|
| Mastectomy, Segmental | 1 | 2020 | 63 | 0.700 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 2012 | 114 | 0.700 |
Why?
|
| Mammaplasty | 1 | 2020 | 41 | 0.690 |
Why?
|
| Neoplastic Stem Cells | 1 | 2019 | 84 | 0.660 |
Why?
|
| Collagen | 3 | 2021 | 636 | 0.630 |
Why?
|
| Mice | 18 | 2017 | 8474 | 0.620 |
Why?
|
| Animals | 23 | 2020 | 20880 | 0.610 |
Why?
|
| Receptors, Growth Factor | 1 | 2017 | 6 | 0.590 |
Why?
|
| Adipocytes | 2 | 2017 | 88 | 0.550 |
Why?
|
| Models, Biological | 2 | 2017 | 981 | 0.530 |
Why?
|
| Carcinogenesis | 1 | 2015 | 124 | 0.470 |
Why?
|
| Biomarkers, Tumor | 1 | 2017 | 508 | 0.450 |
Why?
|
| Female | 22 | 2020 | 38021 | 0.440 |
Why?
|
| Mice, Transgenic | 7 | 2017 | 1033 | 0.440 |
Why?
|
| Sepharose | 1 | 2012 | 18 | 0.430 |
Why?
|
| Laminin | 1 | 2012 | 62 | 0.420 |
Why?
|
| Chitosan | 1 | 2012 | 11 | 0.420 |
Why?
|
| Proteoglycans | 1 | 2012 | 103 | 0.410 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 328 | 0.400 |
Why?
|
| Parity | 2 | 2008 | 71 | 0.380 |
Why?
|
| Hyaluronic Acid | 1 | 2012 | 206 | 0.370 |
Why?
|
| Polyphenols | 2 | 2022 | 34 | 0.370 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 1070 | 0.350 |
Why?
|
| Receptors, Progesterone | 2 | 2008 | 57 | 0.350 |
Why?
|
| Estrogen Receptor alpha | 2 | 2008 | 65 | 0.330 |
Why?
|
| Anaphase | 1 | 2008 | 3 | 0.330 |
Why?
|
| Chromatids | 1 | 2008 | 8 | 0.330 |
Why?
|
| Pregnancy, Animal | 1 | 2008 | 27 | 0.330 |
Why?
|
| Adult Stem Cells | 1 | 2008 | 13 | 0.330 |
Why?
|
| Multipotent Stem Cells | 1 | 2008 | 6 | 0.330 |
Why?
|
| DNA | 2 | 2008 | 597 | 0.320 |
Why?
|
| Cell Division | 2 | 2008 | 541 | 0.320 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2017 | 756 | 0.310 |
Why?
|
| Glycoproteins | 1 | 2009 | 238 | 0.310 |
Why?
|
| Interleukin-13 | 1 | 2007 | 16 | 0.300 |
Why?
|
| Lactation | 2 | 2008 | 110 | 0.300 |
Why?
|
| ADAM Proteins | 1 | 2007 | 53 | 0.290 |
Why?
|
| Pluripotent Stem Cells | 1 | 2007 | 42 | 0.290 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2007 | 126 | 0.270 |
Why?
|
| Caspases | 2 | 2017 | 194 | 0.270 |
Why?
|
| Blotting, Western | 3 | 2015 | 954 | 0.260 |
Why?
|
| ErbB Receptors | 1 | 2007 | 239 | 0.260 |
Why?
|
| Cell Movement | 2 | 2017 | 630 | 0.250 |
Why?
|
| Signal Transduction | 5 | 2015 | 2689 | 0.250 |
Why?
|
| Epidermal Growth Factor | 3 | 2010 | 95 | 0.240 |
Why?
|
| Pregnancy | 6 | 2008 | 2334 | 0.230 |
Why?
|
| Cell Physiological Phenomena | 1 | 2003 | 19 | 0.220 |
Why?
|
| Respiratory Mucosa | 1 | 2003 | 52 | 0.220 |
Why?
|
| Neurons | 1 | 2008 | 881 | 0.210 |
Why?
|
| Cells, Cultured | 4 | 2013 | 2673 | 0.210 |
Why?
|
| RNA, Small Interfering | 2 | 2017 | 434 | 0.210 |
Why?
|
| Humans | 14 | 2019 | 68549 | 0.210 |
Why?
|
| Bromodeoxyuridine | 2 | 2013 | 37 | 0.190 |
Why?
|
| Rats, Nude | 1 | 2020 | 5 | 0.180 |
Why?
|
| Liposarcoma | 1 | 2020 | 13 | 0.180 |
Why?
|
| Homeodomain Proteins | 2 | 2013 | 157 | 0.180 |
Why?
|
| Hydrogen Bonding | 1 | 2020 | 66 | 0.180 |
Why?
|
| Wound Healing | 1 | 2021 | 260 | 0.170 |
Why?
|
| Adiponectin | 1 | 2020 | 52 | 0.170 |
Why?
|
| Antioxidants | 1 | 2022 | 304 | 0.170 |
Why?
|
| Necrosis | 1 | 2020 | 239 | 0.170 |
Why?
|
| Asthma | 1 | 2003 | 345 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 710 | 0.160 |
Why?
|
| Adipose Tissue | 1 | 2020 | 221 | 0.160 |
Why?
|
| RNA, Untranslated | 2 | 2008 | 11 | 0.160 |
Why?
|
| Milk Proteins | 2 | 2008 | 22 | 0.160 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 213 | 0.160 |
Why?
|
| Morphogenesis | 2 | 2008 | 158 | 0.150 |
Why?
|
| Stem Cell Transplantation | 2 | 2008 | 58 | 0.150 |
Why?
|
| Culture Media, Conditioned | 1 | 2017 | 78 | 0.150 |
Why?
|
| Cell Culture Techniques | 2 | 2010 | 189 | 0.150 |
Why?
|
| Templates, Genetic | 2 | 2008 | 9 | 0.150 |
Why?
|
| Epithelium | 2 | 2008 | 172 | 0.150 |
Why?
|
| Inflammation | 2 | 2020 | 1030 | 0.150 |
Why?
|
| Cellular Microenvironment | 1 | 2017 | 10 | 0.150 |
Why?
|
| Receptors, Cytokine | 1 | 2017 | 19 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 444 | 0.140 |
Why?
|
| Macrophages | 1 | 2020 | 647 | 0.140 |
Why?
|
| Neoplasms | 1 | 2007 | 1664 | 0.130 |
Why?
|
| Receptors, Virus | 1 | 2015 | 20 | 0.130 |
Why?
|
| Time Factors | 2 | 2017 | 4655 | 0.130 |
Why?
|
| Fibroblasts | 1 | 2020 | 902 | 0.120 |
Why?
|
| Receptors, Estrogen | 1 | 2015 | 142 | 0.120 |
Why?
|
| Proteins | 2 | 2008 | 473 | 0.120 |
Why?
|
| Transcription Factor HES-1 | 1 | 2013 | 1 | 0.110 |
Why?
|
| Receptor, Notch2 | 1 | 2013 | 3 | 0.110 |
Why?
|
| Deoxyuridine | 1 | 2013 | 8 | 0.110 |
Why?
|
| Receptor, Notch1 | 1 | 2013 | 11 | 0.110 |
Why?
|
| Staining and Labeling | 1 | 2013 | 144 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 58 | 0.110 |
Why?
|
| Cytokines | 1 | 2017 | 866 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 282 | 0.110 |
Why?
|
| Gelatin | 1 | 2012 | 14 | 0.110 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 57 | 0.110 |
Why?
|
| Cell Polarity | 1 | 2012 | 49 | 0.100 |
Why?
|
| Microspheres | 1 | 2012 | 59 | 0.100 |
Why?
|
| Injections | 1 | 2012 | 119 | 0.100 |
Why?
|
| RNA Interference | 1 | 2013 | 266 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2013 | 182 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 532 | 0.100 |
Why?
|
| Cell Nucleus | 1 | 2013 | 305 | 0.100 |
Why?
|
| Drug Combinations | 1 | 2012 | 304 | 0.100 |
Why?
|
| Rats | 1 | 2020 | 5300 | 0.100 |
Why?
|
| Fatty Acids | 1 | 2012 | 222 | 0.100 |
Why?
|
| Cattle | 1 | 2012 | 475 | 0.100 |
Why?
|
| Printing | 1 | 2011 | 9 | 0.100 |
Why?
|
| Prolactin | 2 | 2008 | 61 | 0.100 |
Why?
|
| Cell Adhesion | 1 | 2012 | 324 | 0.100 |
Why?
|
| Cell Lineage | 2 | 2008 | 146 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 1 | 2012 | 852 | 0.090 |
Why?
|
| Basement Membrane | 1 | 2010 | 48 | 0.090 |
Why?
|
| Carcinoma, Embryonal | 1 | 2010 | 4 | 0.090 |
Why?
|
| Matrix Metalloproteinases | 1 | 2012 | 223 | 0.090 |
Why?
|
| Mice, Nude | 2 | 2010 | 294 | 0.090 |
Why?
|
| Kinetics | 1 | 2012 | 1047 | 0.090 |
Why?
|
| Testicular Neoplasms | 1 | 2010 | 27 | 0.090 |
Why?
|
| Cell Transdifferentiation | 1 | 2010 | 12 | 0.090 |
Why?
|
| EGF Family of Proteins | 1 | 2009 | 17 | 0.090 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 53 | 0.090 |
Why?
|
| Biotechnology | 1 | 2010 | 34 | 0.090 |
Why?
|
| Cell Line, Transformed | 1 | 2009 | 100 | 0.090 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2010 | 100 | 0.090 |
Why?
|
| Desmin | 1 | 2008 | 13 | 0.080 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2008 | 29 | 0.080 |
Why?
|
| Keratins | 1 | 2008 | 48 | 0.080 |
Why?
|
| Tritium | 1 | 2008 | 101 | 0.080 |
Why?
|
| Cell Line | 1 | 2013 | 1752 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2009 | 250 | 0.080 |
Why?
|
| beta-Galactosidase | 1 | 2008 | 88 | 0.080 |
Why?
|
| Genes, Reporter | 1 | 2008 | 191 | 0.080 |
Why?
|
| Nerve Growth Factors | 1 | 2008 | 75 | 0.080 |
Why?
|
| Models, Genetic | 1 | 2008 | 161 | 0.080 |
Why?
|
| Mutagenesis | 1 | 2008 | 60 | 0.080 |
Why?
|
| Cell Survival | 2 | 2010 | 901 | 0.080 |
Why?
|
| Transfection | 1 | 2009 | 782 | 0.080 |
Why?
|
| Lac Operon | 1 | 2007 | 54 | 0.080 |
Why?
|
| Integrases | 1 | 2007 | 31 | 0.080 |
Why?
|
| Insulin | 2 | 2008 | 617 | 0.080 |
Why?
|
| Disease | 1 | 2007 | 41 | 0.080 |
Why?
|
| Spheroids, Cellular | 1 | 2007 | 45 | 0.070 |
Why?
|
| Tissue Culture Techniques | 1 | 2007 | 62 | 0.070 |
Why?
|
| Spermatogenesis | 1 | 2007 | 7 | 0.070 |
Why?
|
| Actins | 1 | 2008 | 249 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2008 | 194 | 0.070 |
Why?
|
| Bronchi | 1 | 2007 | 59 | 0.070 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2007 | 52 | 0.070 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2007 | 22 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 132 | 0.070 |
Why?
|
| Cell Cycle | 1 | 2008 | 312 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2010 | 493 | 0.070 |
Why?
|
| Cell Communication | 1 | 2007 | 116 | 0.070 |
Why?
|
| Stromal Cells | 1 | 2007 | 113 | 0.070 |
Why?
|
| Probability | 1 | 2007 | 244 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2007 | 110 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 181 | 0.070 |
Why?
|
| Precancerous Conditions | 1 | 2007 | 74 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 337 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 307 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 507 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2008 | 370 | 0.070 |
Why?
|
| Hydrocortisone | 1 | 2007 | 291 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 614 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2007 | 1040 | 0.060 |
Why?
|
| Genotype | 1 | 2007 | 785 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 1174 | 0.060 |
Why?
|
| Phenotype | 1 | 2007 | 946 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 1753 | 0.050 |
Why?
|
| Biomarkers | 1 | 2008 | 1593 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 765 | 0.050 |
Why?
|
| Male | 4 | 2010 | 37283 | 0.030 |
Why?
|
| Cell Dedifferentiation | 1 | 2010 | 4 | 0.020 |
Why?
|
| Isotonic Solutions | 1 | 2010 | 25 | 0.020 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2010 | 34 | 0.020 |
Why?
|
| Culture Media | 1 | 2010 | 155 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2010 | 100 | 0.020 |
Why?
|
| Regeneration | 1 | 2010 | 105 | 0.020 |
Why?
|
| Ligands | 1 | 2010 | 317 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 306 | 0.020 |
Why?
|
| Netrin-1 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Nanog Homeobox Protein | 1 | 2008 | 6 | 0.020 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2008 | 11 | 0.020 |
Why?
|
| Caseins | 1 | 2008 | 19 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 369 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 40 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2011 | 384 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2008 | 150 | 0.020 |
Why?
|
| Seminiferous Tubules | 1 | 2007 | 3 | 0.020 |
Why?
|
| Genetic Techniques | 1 | 2007 | 32 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2008 | 222 | 0.020 |
Why?
|